From: CCL3 contributes to secondary damage after spinal cord injury
Gene | Fold regulation | p value | Function |
---|---|---|---|
Day 7 | |||
B2m (Beta 2 microglobulin) | − 2.97 | 0.046 | Component of MHC class I molecule [46] |
Bmp7 (Bone morphogenetic protein 7) | − 3.24 | 0.036 | Anti-inflammatory protein, neuroprotective function [47, 48] |
CCl4 (CCL4) | − 5.27 | 0.009 | CCR1 agonist, role in wound repair and inflammation [49] |
Ccl11 (CCL11, eotaxin-1) | − 5.98 | 0.021 | Eosinophil chemotactic protein [50] |
CCl12 (CCL12) | − 4.39 | 0.035 | Pro-inflammatory cytokine [51] |
Cd70 (CD70) | − 3.52 | 0.009 | Pro-inflammatory, promoting T cell responses [52] |
Cx3cl1 (CX3CL1, Fractalkine) | − 5.36 | 0.003 | Chemotactic cytokine [53] |
Ifna2 (IFNα2) | − 5.3 | 0.003 | Pro-inflammatory cytokine with role in anti-tumor immunity [54] |
Il12b (IL12p40) | − 4.90 | 0.008 | Pro-inflammatory cytokine [55] |
Il16 (IL16) | − 9.67 | 0.049 | Chemoattractant for lymphocytes and macrophages [56] |
Il17f (IL17F) | − 5.24 | 0.001 | Pro-inflammatory cytokine [57] |
Il1a (IL1α) | − 2.25 | 0.002 | Pro-inflammatory cytokine [58] |
Il1rn (IL1 receptor antagonist) | − 13.93 | 0.015 | Anti-inflammatory protein [59] |
Il27 (IL27) | − 3.16 | 0.019 | Anti-inflammatory protein [60] |
Mif (Macrophage migration inhibitory factor) | − 2.54 | 0.005 | Pro-inflammatory cytokine [61] |
Osm (Oncostatin M) | − 8.96 | 0.041 | Protein with role in inflammation, hematopoiesis [62] |
Thpo (Thrombopoietin) | − 19.65 | 0.008 | Megakaryocyte growth and development factor [63] |
Tnf (TNF) | − 3.85 | 0.034 | Pro-inflammatory cytokine [64] |
Day 21 | |||
Bmp6 (Bone morphogenetic protein 6) | − 2.32 | 0.034 | Iron metabolism [65] |
Ifng (IFNγ) | − 4.2 | 0.031 | Pro-inflammatory cytokine [66] |
Pf4 (Platelet factor 4/CXCL4) | − 2.76 | 0.008 | Pro-inflammatory chemokine [67] |
Thpo (Thrombopoietin) | − 2.89 | 0.036 | Megakaryocyte growth and development factor [63] |
Tnfrsf11b (Osteoprotegerin) | − 14.42 | 0.031 | Inhibitor of osteoclast function [68] |